SGLT2 inhibitors improve FIB-4 index, a marker of liver fibrosis, in hypertensive patients with type2 diabetes mellitus

○Miki Uchihashi

[29P-pm422S] SGLT2 inhibitors improve FIB-4 index, a marker of liver fibrosis, in hypertensive patients with type2 diabetes mellitus

○Miki Uchihashi¹, Satoyasu Ito¹, Rina Uchikoshi¹, Yumika Okada¹, Yuta Kitamura¹, Hyocheon Kim¹, Tsukiko Tomita¹, Yoshiro Naito², Masanori Asakura², Masaharu Ishihara², Takeshi Tsujino^1,2 (1. School of Pharmacy, Hyogo Medical University, 2. Department of Cardiovascular and Renal Medicine, Hyogo Medical University)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[29P-pm] Clinical Pharmacy

[29P-pm422S] SGLT2 inhibitors improve FIB-4 index, a marker of liver fibrosis, in hypertensive patients with type2 diabetes mellitus

Password